Advertisement - Members don't see this ad
Generic Lovenox!!
Sanofi can take their Frenchy whiny ass back across the Atlantic!
Momenta Pharmaceuticals Inc. may become the first drugmaker to win U.S. clearance to sell generic versions of a biotechnology medicine, getting a head start on President Barack Obamas plan to trim health-care costs by making such copycats commonplace.
Lovenox is Sanofis biggest product. The Paris-based drugmaker has urged the FDA to reject generics of that medicine, because the Lovenox molecule isnt fully characterized and cant be duplicated. Teva says the same thing about Copaxone, which generated $2.26 billion in 2008.
Sanofi can take their Frenchy whiny ass back across the Atlantic!